Skip to main content
OpenTrials

Clinical trial condition

Pyloric Stenosis, Hypertrophic

Explore clinical trials studying Pyloric Stenosis, Hypertrophic. Study availability and eligibility vary by location and protocol.

30 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Pyloric Stenosis, Hypertrophic trial results

Completed

Access in Dialysis for Better Outcomes in Patient Therapy

NCT03109574

Conditions
Catheter-related Bloodstream Infection (CRBSI) Nos, Central Venous Catheter, Digestive System Diseases, +5 more
Locations
  • William Osler Health System Brampton, Ontario, Canada
  • Halton Healthcare Oakville, Ontario, Canada
  • Niagara Health System Saint Catharines, Ontario, Canada
View Trial Details
Completed

Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma

NCT00884546

Conditions
Advanced Cancer, Various, NOS, Digestive System Diseases, Gastric Outlet Obstruction, +4 more
Locations
  • City Of Hope National Medical Center Duarte, California, United States
  • Moores Ucsd Cancer Center La Jolla, California, United States
  • Local Institution Los Angeles, California, United States
  • The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

PoC in Rheumatoid Arthritis With Methotrexate

NCT00605735

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +13 more
Locations
  • Desert Medical Advances Palm Desert, California, United States
  • Orrin M. Troum,M D Santa Monica, California, United States
  • G. Timothy Kelly, Md Las Vegas, Nevada, United States
  • Health Research Of Oklahoma Oklahoma City, Oklahoma, United States
View all 28 locations
View Trial Details
Completed

Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)

NCT01046864

Conditions
Digestive System Diseases, Gastric Outlet Obstruction, Gastro-Intestinal Cancer, +4 more
Locations
  • Usc/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Texas Oncology Dallas, Texas, United States
  • Scott & White Memorial Hospital And Clinic Temple, Texas, United States
  • Local Institution Edmonton, Alberta, Canada
View Trial Details
Active, Not Recruiting

Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas

NCT05583149

Conditions
Aggressive B-cell NHL, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions